The Organisation for Economic Co-operation and Development (OECD) works with member countries and other stakeholders to improve and harmonize chemical assessment methods. In 2012, the OECD Adverse Outcome Pathways (AOPs) Development Programme started. The Programme has published six AOPs thus far and more than 60 AOPs are under various stages of development under the Programme. This article reviews recent OECD activities on the use of AOPs in developing Integrated Approaches to Testing and Assessments (IATAs). The guidance document for the use of AOPs in developing IATA, published in 2016, provides a framework for developing and using IATA and describes how IATA can be based on an AOP. The guidance document on the reporting of defined approaches to be used within IATA, also published in 2016, provides a set of principles for reporting defined approaches to testing and assessment to facilitate their evaluation. In the guidance documents, the AOP concept plays an important role for building IATA approaches in a science-based and transparent way. In 2015, the IATA Case Studies Project was launched to increase experience with the use of IATA and novel hazard methodologies by developing case studies, which constitute examples of predictions that are fit-for-regulatory use. This activity highlights the importance of international collaboration for harmonizing and improving chemical safety assessment methods.
The Organisation for Economic Co-operation and Development (OECD)'s Environment, Health and Safety Programme deals with the safe use of chemicals, nanomaterials, pesticide, biocides and novel foods and feed. Its aims are to protect health and the environment, while avoiding duplication of effort ensuring that efficiencies are made and barriers to trade avoided. To accomplish these aims, the OECD works with member countries and other stakeholders to improve and harmonize chemical assessment methods. The results from the OECD activities such as test guidelines, guidance documents and computer tools have been widely used to support chemical safety regulations in many countries [1] .
The need to assess the hazards and risks of thousands of existing chemicals is a common challenge for regulators in many countries. Often, there is inadequate information available upon which to base these assessments. Recently, the OECD has worked on two concepts to help address this issue. Integrated Approaches to Testing and Assessment (IATA) is a concept that can be applied to derive regulatory decisions by integrating different types of information such as in silico, in chemico, in vitro and in vivo. Adverse outcome pathways (AOP) are a concept applied to understand and to organize the key events within biological pathways which lead to adverse outcome induced by chemicals. According to a recent OECD guidance document [2] , IATA and AOP are defined as follows:
Integrated Approaches to Testing and Assessments are pragmatic, science-based approaches for chemical hazard characterization that rely on an integrated analysis of existing information, coupled with the generation of new information using testing strategies. IATAs follow an iterative approach to answer a defined question in a specific regulatory context, taking into account the acceptable level of uncertainty associated with the decision context.
An AOP is a logical sequence of key events (KEs) triggered by chemical exposure and occurring at each level of biological organization such as molecular, organelle, cellular, organ and organism levels. These KEs are causally linked to the adverse outcome under consideration, and they are measurable. The AOP is anchored at one end by a molecular initiating event (MIE), which represents the direct interaction of a chemical with a biological target. At the other end, the AOP is anchored by an adverse outcome (AO) at the organism or population level. An AOP allows for the mapping, organization and integration of various types of information such as in silico, in chemico, in vitro and in vivo data [3, 4] .
In 2010, the first OECD workshop on AOPs was held [5] . The workshop identified that an AOP approach can be used to inform an IATA by providing: 1 Plausible and transparent means of linking molecular initiating events to the in vivo outcome of regulatory interest and making uncertainties explicit. 2 Conceptual framework for organizing information at different levels of biological organization, characterizing the weight of evidence. 3 Means of forming categories based on both intrinsic chemical and biological activities.
Based on a recommendation from the workshop, the OECD developed an AOP on skin sensitization as a proof of concept [6, 7] . The AOP is implemented in the OECD QSAR Toolbox, which is a tool to fill missing data based on grouping of chemicals [8] . The AOP on skin sensitization is used in the recent updated standard information requirements of European Union's (EU's) Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) [9] . In 2012, the OECD AOP Development Programme started [10] . The first five AOPs were published in August 2016 [11] [12] [13] [14] [15] . Table 1 includes the list of published AOPs. More than 60 AOPs are under various stages of development [16] . These AOPs are stored in the AOP knowledge base (AOP-KB) [17] . The overview of the OECD activities on developing AOPs is summarized in a recent review paper [18] .
In addition to the developments of AOPs, activities related to use of AOPs have recently been increasing in member countries [19] [20] [21] [22] . At this point, the AOP for skin sensitization is the most widely used, although there are five other AOPs published via the OECD process (table 1) . There is a need to investigate the way of use of different AOPs. In response to the situation, the OECD has recently started several activities related to use of AOPs for developing IATA which are reviewed in this article.
Guidance on the Use of AOPs in Developing IATA
In November 2014, an OECD workshop on the development of a framework for IATA was held [23] . Based on the outcome from the workshop, a guidance document for the use of AOPs in developing IATA has been developed [2] . The objective of this guidance document is to provide a framework for developing and using IATA and describe how IATA can be based on the AOP. Figure 1 shows the framework of IATA described in the guidance document. The first step is 'Problem Formulation'. For example, the regulatory question and decision context, end-point of interest and acceptable uncertainty are identified. Once the problem is defined, AOPs allow one to evaluate, in a structured way, the existing information that is available for the chemical of interest. And then, one can identify whether the existing information is adequate for decision-making by weight of evidence assessment [see, e.g. 24, 25] . If the existing information is not adequate, an AOP can also help develop a testing strategy. As such, an AOP iteratively aids in identifying which information is available, or needs to be generated, in order to make a regulatory decision. Figure 1 also shows an example of an IATA applied in a case study (2016-5), which is further described in the IATA Case Studies Project section of this article [26] .
The guidance document provides five examples of how AOPs can be used in the development of IATA. The summaries of the examples are as follows:
Development of (Q)SARs. The MIE in each AOP may be used for generating mechanistically based structure-activity relationships (SARs) that can be used to predict whether a chemical can trigger an AOP. This concept has been implemented within the OECD QSAR Toolbox for skin sensitization [27] .
Grouping of chemicals into chemical categories.
Chemicals that are shown to activate the same AOP, based on the results of assays or predictions of the MIE or KEs, can be grouped together, thereby improving the robustness of the data gap filling approach for the AO. Development of testing strategies. The AOP concept can be used to develop testing strategies for end-points of interest by combining assays or prediction models that evaluate specific KEs along a particular AOP. The guidance provides an example of such testing strategy based on AOP.
Interpretation of results from non-standard test methods. Linking a non-standard test method (e.g. omic data) to a KE in an AOP provides context for understanding how to interpret these types of results and link them to an AO.
Selection of methods for test guideline development/ refinement. By linking KEs in an AOP to in vitro test methods for specific informative KEs, high priority areas for test method development can be identified. Focusing on tests for key events can decrease the overall number of assays required for hazard identification. These examples clearly show that the AOP concept can be used for various stages of IATA covering chemical assessment, development of test methods/QSAR models and testing strategies while playing an important role in harmonizing IATA approaches via a science-based and transparent manner.
Guidance Documents on the Reporting of Defined Approaches
Defined approaches are rule-based approaches to integrate different types of information, which can be used as an element of IATA. A guidance document on the reporting of defined approaches to be used within IATA was published in October 2016 [28] . According to the guidance, 'a defined approach consists of a fixed data interpretation procedure (DIP) (e.g.
statistical, mathematical models) applied to data (e.g. in silico predictions, in chemico, in vitro data) generated with a defined set of information sources to derive a prediction. In contrast to the assessment process within IATA, that necessarily involves some degree of expert judgement, predictions generated with defined approaches are rule-based and can either be used on their own if they are deemed to fit-for-purpose or considered together with other sources of information in the context of IATA'. This guidance document provides a set of principles and templates for reporting defined approaches to testing and assessment. These tools help to document defined approaches consistently, which facilitates not only their evaluation but also the use of IATA in regulatory decision-making within OECD member countries.
The general principles for the reporting of defined approaches outlined in the guidance document are as follows:
To facilitate the regulatory use of a defined approach to testing and assessment, which is based on a fixed DIP and a defined set of information sources, the defined approach should be associated with the following set of information: 1 A defined end-point 2 A defined purpose 3 A description of the underlying rationale 4 A description of the individual information sources used 5 A description of how data from the individual information sources are processed 6 A consideration of the known uncertainties
The Principle 3 ensures transparency in the rationale used for constructing the defined approach. An AOP can be used to fulfil the principle. The two templates available in the document describe how AOP information should be reported.
To illustrate reporting of defined approaches for a specific end-point, a guidance document focused on defined Fig. 1 . Framework for how an adverse outcome pathway can be applied to inform and structure Integrated Approaches to Testing and Assessment in a decision context [2] and an example from a case study [26] . approaches in the area of skin sensitization was also published [29] . This guidance document provides mapping of information sources that can be used within defined approaches and IATA for skin sensitization by applying the AOP as a framework. The guidance document contains 12 case studies of defined approached for skin sensitization developed by different countries.
These guidance documents complement other existing OECD guidance for harmonizing reporting approaches for QSARs [30] , grouping and read-across strategies [31] , and non-guideline in vitro methods [32] .
IATA Case Studies Project
Objectives of the project. The OECD Cooperative Chemicals Assessment Programme (CoCAP) and its predecessor, the High Production Volume (HPV) Chemicals Programme, had focused on deriving OECD-wide agreed hazard assessments of chemicals. In the Programmes, the hazards of more than 1200 chemicals were assessed. In 2014, the CoCAP was again updated to focus on the needs of countries and was revised to enhance the activity on the development and the application of IATA [33] . This Programme provides a forum for scientific exchange of approaches on how novel methods are applied to assess the hazard of chemicals and establish common and best practices for the use of these methods for assessing different types of chemicals.
As mentioned in the previous sections, the OECD has been developing guidance documents and tools for the use of alternative methods such as (Q)SAR, grouping of chemicals and AOPs. However, there is a continuing need to demonstrate and explore where these tools and methods have practical applicability as a part of IATA, for different aspects of regulatory decision-making and to build upon case studies and assessment experience across jurisdictions. The IATA Case Studies Project was launched in 2015 under the revised CoCAP to increase experience with the use of IATA by developing case studies. Figure 2 illustrates the concept of the IATA Case Studies Project. These case studies aim to be examples that have been used, or could be used, in different regulatory contexts [34] . The case studies are vehicles to create a common understanding of using novel methodologies and also to identify where further guidance may be needed to facilitate their use and uptake.
Review process.
The project team consists of representatives from OECD member countries and other stakeholders. The following 13 countries/organizations participated in the first two review cycles: Australia, Canada, Denmark, Germany, Japan, the Netherlands, Sweden, the United States (US), EU/European Commission (EU/EC), EU/Joint Research Centre (EU/JRC), EU/European Chemicals Agency (EU/ECHA), Business and Industry Advisory Committee to the OECD (BIAC) and International Council for Animal Protection in OECD Programmes (ICAPO).
This project team reviews case studies submitted from member countries and other stakeholders every year. Table 2 shows the list of case studies reviewed in the first two review cycles (2015-2016) [26, [35] [36] [37] [38] [39] [40] [41] [42] . Some case studies were developed based on actual use of IATA in different regulatory contexts of member countries, and some case studies were developed based on the results of national/regional research projects. Seven case studies of nine case studies focus on read-across. In all case studies, the target chemicals were selected by member countries to illustrate good examples of an IATA approach.
The review results are discussed in a project meeting. The discussion includes topics such as the strongest aspects of case study, the areas of uncertainty in a case study, areas for further developing guidance and possibility or impediments to use of the approach within the case study in different regulatory contexts. In every review cycle, the case studies are published with a considerations document capturing the learnings and lessons stemming from case studies [43, 44] . A summary of the considerations documents of the first and second reviews cycles are described in the following subsections.
Methods illustrated by case studies.
For the seven case studies on read-across, a template developed within the project, based on the reporting format of the OECD grouping guidance [31] , was used. Therefore, concrete examples of the approaches described in the grouping guidance can be found in the case studies. One example is building hypotheses based on mechanistic information. Whereas conventional grouping methods have often been conducted only based on structural similarity, recent guidance recommends to build a read-across hypothesis based on mechanistic information such as AOPs to increase the reliability of category [31] . Most typical approaches for mechanistic grouping are based on knowledge of the MIE. Two case studies (2015-1, 3) illustrate how to build a hypothesis for read-across based on an MIE to obtain reliable prediction results.
However, a MIE is not available in every case of read-across. The other five read-across case studies illustrate that the reliability of read-across can also be enhanced using mechanistic information other than the MIE. For example, in the two case studies (2016-3,4), the chemical category represents analogues which are non-reactive and exhibit non-polar narcosis. In the case studies, the data from high-throughput screening (HTS) assays and in silico profilers was used to support the hypothesis that the category members do not have a specific bioactivity such as receptor binding. Every read-across case study also illustrates that the hypothesis can be justified using different types of information such as omic, QSAR and metabolism data.
The considerations documented from the second review cycle [44] especially focus on read-across for repeated dose toxicity, because five case studies of this area have been obtained from the first and second review cycles. Lessons learned from two case studies (2016-3,4) include factors for increasing acceptance of a read-across prediction for complex end-points and the opportunities for reducing uncertainty to increase confidence of a read-across prediction. Also, each of the five case studies addressed specific issues such as use of new approach methodologies and reported uncertainty in order to capture concrete examples to be potentially used for further guidance. Two case studies illustrated the use of AOP in developing IATA other than read-across. The purpose of one case study (2016-2) is to highlight how AOP knowledge can be used to design a testing strategy to focus on potential for life susceptibility for an entire class of pesticides and how the associated data have been used to assess cumulative risk. The case study was developed based on a cumulative risk assessment for organophosphate pesticides by US Environmental Protection Agency (US EPA) which was conducted based on the US EPA guidance document on Organophosphorous Pesticide Cumulative Risk Assessment [45] .
The other case study (2016-5) presents a general workflow, which was developed based on the SEURAT-1 (Safety Evaluation Ultimately Replacing Animal Testing) conceptual framework for safety assessment [46, 47] , in an attempt to structure knowledge and data in a logical sequence for an integrated chemical safety assessment relying specifically on alternative methods and based on exposure considerations. In an example to illustrate such a workflow, the data gathered pointed at respective molecular initiating events and target organs and the incorporation of physiologically based kinetic modelling were used to identify the AOPs for liver steatosis and liver fibrosis as a relevant framework for organizing the assessment. Based on the AOPs and their KEs, relevant in vitro assays were identified for targeted testing to confirm the mode of action (MOA) hypothesis. The AOP of liver fibrosis used in the case study is published as a complete AOP from OECD [11] (No. 2 in table 1 ). This case study provides a good example of the use of KE in AOPs, whereas the main AOP information used in other case studies is the MIE.
Uncertainty within a case study. The case studies are used to demonstrate IATA in a specific regulatory context. Within these contexts, there is a need to balance pragmatism and 'ideal' scenarios, where perhaps more time, information and resources would be needed. Therefore, each case study contains different uncertainties. However, the fit-for-purpose approach needs to be scientifically sound.
The template used within the case study of the project includes a section for reporting uncertainties identified by authors. In addition, uncertainties identified by reviewers were described in the considerations document. For example, one of the dominant uncertainties identified in many read-across case studies was level of confidence in the hypothesis for read-across and the correlation of knowledge of the mechanistic basis to structural features, metabolism and adverse effects observed.
The considerations documents highlight how consideration of uncertainty is helpful to improve the case studies and how the uncertainty analysis helped the reviewers to consider the impacts of uncertainty and the acceptable degree of uncertainty with respect to the purpose of use of the case studies.
Possibility of the use of case study in other regulatory context. During the review process for each case study, reviewers are asked whether they would use the results of such a case study in their regulatory context and if not, for what reason. The answers from different countries are described in the considerations documents. For example, reviewers form EU countries provide perspectives on if particular read-across case studies could be used under REACH.
Such discussions help to understand how the approaches used in a case study could be used for other purposes. In particular, the review experience highlighted the importance of the need for a very clear description of the application, scope and framework for which the case study is used. This provides context for the reader with regard to what aspects will be addressed by the case study, what level of detail in reporting is required, and what level of uncertainty might be accepted.
Identified areas for further development of guidance. Based on the review results, the project team discusses areas for further development of guidance. A summary of the highest priority areas identified in the first two review cycles are as follows:
Building hypotheses based on MOA/AOP. It was identified that hypotheses could be better elaborated and that further illustration of how to use mechanistic information/AOPs to build a hypothesis, in particular for read-across, would increase confidence in the approaches used in the case studies.
Definition of analogues/category boundaries chemical similarity. It was pointed out that how to describe clear category boundaries can be improved for all end-points. In particular, it was noted that structural similarities in the chemical structures of analogues were discussed but the potential impact of structural differences was often not well accounted for.
Incorporation of new approach methodologies. Based on the review experience, use and reporting of new approach methodologies (NAMs) such as HTS assays and omics in IATA were identified as a potential area for further developing guidance; however, it was also thought that more experience in the use of the methods within regulatory IATA will also be helpful. It is mentioned that the template for reporting individual information sources in the OECD guidance document on defined approaches [28] could be used for reporting of NAMs.
Decision logic for low/no toxicity predictions. It was identified that read-across approaches are typically developed for positive predictions. However, the considerations for prediction of no/low toxicity are also important and could benefit from a harmonized approach.
Uncertainty analysis and reporting. The importance of capturing and communicating uncertainty was highlighted as a key issue and also demonstrated in the case studies. The existing uncertainty templates [48] [49] [50] used in case studies 2016-3, 2016-4, 2015-1 and 2015-2 could be used to begin to develop guidance in this area.
Many different areas were identified for guidance development. This reflects the large variety of the types of data and evaluation methods used in IATA. The most fundamental and the highest priority area has been identified as 'uncertainty analysis and reporting'. Existing guidance documents mainly provide guidance on how to demonstrate the reliability of data and methods used for an evaluation. However, an IATA generally considers new data and methods whose reliabilities are not as well-established. Therefore, it is important to identify uncertainties and to consider their impact on the conclusions drawn in a particular IATA context. For example, the guidance on grouping of chemicals [31] describes that MIEs are useful to support the structural similarities of analogues used for read-across, but there is no description how to discuss the uncertainties due to their structural differences. International guidance on analysing and reporting uncertainties in IATA is needed to facilitate and promote the use of IATAs in a regulatory context.
Outlook of the project.
As highlighted in the considerations documents of first and second review cycles [43, 44] , the use of case studies has enabled the sharing of experience gained on the use of alternative methods and approaches across countries. This type of collaboration will help to expand the use in particular regulatory contexts, identify areas of uncertainty and move towards convergence in how new tools and approaches are used. It has also been recognized that more case studies are needed for developing general guidance. Therefore, there is a need to build upon aspects identified through the review of these first two sets of case studies by incorporating the review experiences of future case studies.
In the third review cycle, four case studies are under review (table 3) . The case studies include several new areas to the project such as nanomaterials and ecotoxicity. It is envisioned that future rounds of case studies will include grouping and read-across approaches but also address a wider diversity of case studies examining additional IATA approaches and the use of novel approaches.
Conclusions
Recent OECD activities related to the use of AOP in developing IATA have been reviewed. Three guidance documents reviewed in the article provide international approaches for developing and documenting IATAs and defined approaches. In each guidance document, the AOP concept plays an important role for harmonizing IATAs in a science-based and transparent manner.
The IATA Case Studies Project has been launched to increase experience with the use of IATA by developing case studies, which constitute examples of predictions that are fitfor-regulatory use. Nine case studies reviewed in the first two review cycles have been published. The case studies illustrate methods described in different OECD guidance documents and newer methods related to IATA and also explore the use of AOPs. Based on the review experience, a considerations document is published in every review cycle, which is capturing lessons and learnings and identifies areas for further developing guidance. This activity highlights the importance of international collaborations for harmonizing and improving chemical safety assessment methods.
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